Industry Experts

Andrew Heron is CEO & Co-founder of Portal Biotech Limited. Andy was previously a senior member of the Oxford Nanopore Technology team that was responsible for commercialising its range of gene sequencers. Andy has made significant contributions to the field of nanopore technology in the last 15 years with over 40 patents and multiple publications and brings this knowledge and experience to bear in accelerating Portal’s new products pipeline. Andy completed post-doc work at the Department of Chemistry, Oxford University and has a PhD in chemical biology from Imperial College, London.